MSB 1.41% $1.05 mesoblast limited

Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes, page-522

  1. 55 Posts.
    lightbulb Created with Sketch. 22
    If you were a medical professional as you purport to be, and given the amount of time you have spent on this thread, you would have known full well that Perin et al are not engaged in post hoc data analysis of the trial results. You would also be aware that this line has been pushed by Whytee and other downrampers on this thread, yet you chose to post an article about post hoc analysis hype. Why did you do that if it wasn't to reinforce some of the downramping crap posted by others? When LED called you out on it you did an awkward backflip saying it wasn't targeted at MSB and then quickly googled to find something to post about pre specified subgroup analysis.
    I think you're a disingenuous squirmer who wishes to present as a font of balanced opinion, while subtly pushing a downramping agenda. In many ways I prefer edwin over you. He's a single celled animal who knows or cares nothing about the science, can barely string a sentence together, just wants the share price to go down. Least he's honest and not up his own a...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.05
Change
-0.015(1.41%)
Mkt cap ! $1.198B
Open High Low Value Volume
$1.09 $1.09 $1.05 $4.232M 3.978M

Buyers (Bids)

No. Vol. Price($)
4 61694 $1.05
 

Sellers (Offers)

Price($) Vol. No.
$1.06 45910 3
View Market Depth
Last trade - 16.10pm 15/05/2024 (20 minute delay) ?
Last
$1.06
  Change
-0.015 ( 0.63 %)
Open High Low Volume
$1.09 $1.09 $1.05 969435
Last updated 15.59pm 15/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.